Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00085865 · ClinicalTrials.gov registry record

Serotonin Transporters in Alcoholism

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
60
Enrollment target

NCT00085865 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00085865 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

This study will compare serotonin transporter proteins in people with alcoholism and healthy volunteers to examine how these proteins may be related to the inability of people with alcoholism to appropriately regulate their alcohol consumption. Serotonin transporters regulate levels of the brain chemical serotonin. Problems in this regulation have been implicated in alcoholism. Healthy normal volunteers and people who suffer from alcoholism who are between 18 and 75 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, psychiatric diagnostic interview, blood and urine tests, an electrocardiogram, urine toxicology screen, and written psychological evaluations. Participants undergo positron emission tomography (PET) and magnetic resonance imaging (MRI) scanning to measure serotonin transporter levels in the brain. PET uses small amounts of a radioactive chemical called a tracer that "labels" the serotonin transporters in the brain. The tracer used in this study is \[11C\]DASB. For the procedure, the subject lies on the scanner bed. A special mask is fitted to the head and attached to the bed to help keep the subject's head still during the scan so the images will be clear. A brief scan is done just before the radioactive tracer is injected. This scan provides measures of the brain that will help in the precise calculation of information from subsequent scans. After the tracer is injected through a catheter (plastic tube) placed in the arm, pictures are taken for about 2 hours. MRI uses a magnetic field and radio waves to produce pictures of brain structure. The subject lies on a bed that slides into the tube-like scanner, wearing earplugs to muffle loud noises the machine makes when the magnetic fields are switched. The scan takes about an hour, during which time the subject can communicate with the technician.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2004-06
Est. Completion 2006-07

What the Registry Record Tells You About NCT00085865

The ClinicalTrials.gov registry entry for NCT00085865 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00085865 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00085865 about?

NCT00085865 is a clinical study titled "Serotonin Transporters in Alcoholism". This study will compare serotonin transporter proteins in people with alcoholism and healthy volunteers to examine how these proteins may be related to the inability of people with alcoholism to appropriately regulate their alcohol consumption. Serotonin transporters regulate levels of the brain che...

What is the current status of trial NCT00085865?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2004-06. Estimated completion is 2006-07.

Who is sponsoring clinical trial NCT00085865?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.